Healthcare
Live Price
Offline$23.99
+0.04% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Abcam plc (ABCM) is a Healthcare stock with a market cap of $5.52B and listed on NASDAQ. The stock last traded around $23.99. Baseline metrics include revenue growth of -43.2%, EPS growth of -135.3%, a dividend yield of 0.0%. What stands out right now is revenue -43.2%, EPS -135.3%, free cash flow -118.5% with operating margin 2.0% and ROIC 0.6%. Valuation already assumes a fairly strong business story at P/E 578.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ABCM price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ABCM
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ABCM Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ABCM and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$259.9M
-0.0% YoY
FY Net Income
$45.0M
+260.0% YoY
Free Cash Flow
$29.8M
+9.2% YoY
Revenue Growth
-43.2%
EPS Growth
-135.3%
Gross Margin
71.2%
Net Margin
1.4%
Income statement
GBP
| Metric | 2022 | 2021 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 362M | 637M | 298M | 260M | 260M |
| Gross Profit | 271M | 413M | 212M | 180M | 183M |
| Operating Income | -10M | 63M | 26M | 11M | 56M |
| EBITDA | 43M | 142M | 29M | 41M | 93M |
| Net Income | -9M | 24M | 15M | 13M | 45M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
GBP
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 89M | 95M | 190M | 87M | 90M |
| Total Assets | 1.1B | 986M | 622M | 447M | 415M |
| Total Liabilities | 330M | 330M | 233M | 62M | 63M |
| Shareholder Equity | 727M | 656M | 390M | 385M | 352M |
| Total Debt | 224M | 230M | 175M | 0 | 0 |
| Net Debt | 135M | 135M | -15M | -87M | -90M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
70M
+11.4% YoY
Capital Expenditures
40M
-13.2% YoY
Free Cash Flow
30M
+9.2% YoY
Key ratios
Gross Margin
71.2%
Operating Margin
2.0%
Net Margin
1.4%
ROE
0.8%
Debt / Equity
0.35x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.